Tachycardia

The rate of exposure to synthetic THC among children in the United States increased by 132% during a recent 2-year period, according to data from the American Association of Poison Control Centers published in Clinical Toxicology.

Healio and Cardiology Today have compiled a list of the most-read cardiology news of October 2023.

Medtronic announced it received FDA approval for its extravascular implantable cardioverter-defibrillator and defibrillation lead to treat tachycardia that may cause sudden cardiac arrest.

PHILADELPHIA — Postural orthostatic tachycardia syndrome is a common cardiac complication in COVID-19 survivors and research is ongoing as to optimal treatments, a speaker said during the Heart in Diabetes CME Conference.

In adults with scar-related ventricular tachycardia, a strategy of ventricular tachycardia ablation plus implantation of a subcutaneous implantable cardioverter defibrillator led to better outcomes than use of a transvenous ICD, data show.

WASHINGTON — Those with incomplete COVID-19 vaccination faced elevated risk for nonrespiratory features, such as fever and tachycardia, according to research presented at the American Thoracic Society International Conference.

The odds for developing new postural orthostatic tachycardia syndrome within 90 days after COVID-19 vaccination were more than five times lower compared with likelihood after SARS-CoV-2 infection, researchers reported.

Intramural needle ablation using in-catheter, heated saline-enhanced radiofrequency was effective in reducing ventricular tachycardia burden for high-risk patients failing one to five prior ablations and drug therapy, researchers reported.

Ablation vs. standard care after first ICD shock for ventricular tachycardia.

WASHINGTON — Ablation soon after first implantable cardioverter defibrillator shock for ventricular tachycardia conferred better event-free survival compared with standard care, a speaker reported.